INTERNATIONAL PATENT: ASTELLAS PHARMA INC. FILES APPLICATION FOR "STING AGONIST IMMUNOSTIMULATORY ANTIBODY DRUG CONJUGATES"

GENEVA, Dec. 10 -- ASTELLAS PHARMA INC. (2-5-1, Nihonbashi-Honcho, Chuo-KuTokyo, 103-8411) filed a patent application (PCT/US2025/031491) for "STING AGONIST IMMUNOSTIMULATORY ANTIBODY DRUG CONJUGATES" on May 29, 2025. With publication no. WO/2025/250831, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Xiaofan (c/o Sutro Biopharma, Inc.111 Oyster Point BoulevardSouth San Francisco, California 94080), KIEFEL, Helena (c/o Sutro Biopharma, Inc.111 Oyster Point BoulevardSouth San Francisco, California 94080), WEN, Miao (c/...